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Abstract: Staphylococcus aureus is a leading pathogen
for animals and humans, not only being one of the most
frequently isolated bacteria in hospital-associated infec-
tions but also causing diseases in the community. To
coordinate the expression of its numerous virulence
genes for growth and survival, S. aureus uses various
signalling pathways that include two-component regula-
tory systems, transcription factors, and also around 250
regulatory RNAs. Biological roles have only been deter-
mined for a handful of these sRNAs, including cis, trans,
and cis-trans acting RNAs, some internally encoding small,
functional peptides and others possessing dual or
multiple functions. Here we put forward an inventory of
these fascinating sRNAs; the proteins involved in their
activities; and those involved in stress response, metab-
olisms, and virulence.
Introduction
Staphylococcus aureus is a commonly isolated bacterial pathogen in
humans and animals and a serious threat to health. It can live as a
commensal but, provided suitable opportunity, can initiate severe
infections at various body sites. S. aureus is one of the most
frequently isolated pathogens in hospital-associated infections but
can also cause diseases in the community [1]. Nosocomial and
community-acquired S. aureus infections include superficial skin
lesions such as boils, abscesses, and impetigo, while invasive
infections include septic arthritis, pneumonia, osteomyelitis,
and endocarditis. S. aureus is an aggressive pathogen due to the
combination of elevated antibiotic resistance and prominent
virulence. The virulence of S. aureus is defined by a series of
determinants that are often redundant in their functions. This
bacterium produces an array of cell surface and secreted factors,
including proteins that promote adhesion to host cells and tissues
and some that bind proteins in blood toevade triggered immune
responses. The organism also secretes extracellular enzymes
such as proteases, a hyaluronidase, a lipase, and a nuclease that
facilitate host tissue destruction and spreading. It produces
membrane-damaging toxins that lyse host cells, as well as
superantigens that are immunostimulatory exotoxins [2].
To face and adapt to various environmental conditions,
including host colonization and spreading, S. aureus possesses
many signaling pathways, some that are redundant, to coordinate
the expression of its numerous virulence genes. At least 12 two-
component regulatory systems and several transcription factors
control these regulatory circuits, with multiple and intricate
interplays to specifically reprogram the expression of target genes
for continuous adaptation. Dozens of regulatory RNAs (sRNAs)
are also involved in such dedicated control of gene expression,
but their direct mRNA targets are, for the most part, currently
unknown. Additionally, translation control and decay of selected
S. aureus mRNAs, in response to specific signals during S. aureus
growth and adaptation, can be achieved by specific ribonucleases
[3] organized into large multi-enzyme complexes [4]. Widespread
mRNA antisense transcription all over the S. aureus genome [5], as
well as dedicated cis and trans sRNAs (reviewed in [6,7]), actively
participate in these gene expression controls.
More than 250 srna genes were discovered and detected as
expressed transcripts in various S. aureus strains and experimental
conditions [8–15]. The vast majority of these sRNAs are only
expressed in S. aureus, a few are detected in Bacillaceae (e.g. RsaE),
and several housekeeping sRNAs are detected in all eubacteria
(e.g. tmRNA, RNase P RNA, 6S RNA). Most S. aureus sRNAs are
located within the core genome, with a few expressed from the
pathogenicity islands and from plasmids. For the most part, their
functional, structural, and mechanistic details are unknown. This
review will focus on the current functional understanding of cis-
and trans- regulatory RNAs expressed in this organism, the unusual
cases of cis sRNAs acting in trans, those expressing small peptides,
and the sRNAs possessing multiple functions. We will exclude the
S. aureus riboswitches that are cis-acting regulatory domains of
mRNAs. The various proteins associated with S. aureus sRNA
functions will be described, including the controversial roles of
Hfq. The emphasis will be placed on sRNAs involved in stress
response and metabolisms and on several sRNAs implicated in S.
aureus pathogenesis.
A Multiplicity of sRNAs Expressed by S. aureus
Cis-encoded antisense RNAs
Cis-encoded antisense sRNAs are transcribed on the strand
opposite to their target mRNAs [16,17] and regulate gene
expression by base-pairing with their complementary mRNAs
(Figure 1A). Despite an extended complementarity with their
primary target encoded on the opposite DNA strand, the initial
interaction between the mRNA and the sRNA, ‘‘a kissing inter-
action,’’ occurs by contact between a few nucleotides usually
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located in accessible hairpins. This interaction is followed by
additional pairings involving structural rearrangements of the
two interacting RNAs [18]. In S. aureus, the first cis-encoded sRNA
identified controls the rolling-circle replication of plasmid pT181
by transcriptional attenuation [13]. pT181 regulates its replication
by the expression of an antisense RNA (RNAI) that blocks the
expression of the plasmid-encoded replication initiation protein
RepC. This mechanism involves pairings between complementary
loops in the mRNA leader and the antisense RNA, which results in
the formation of a transcription-termination hairpin 59 to the Rep
initiation codon. Attenuation is very efficient, aborting .90%
of the Rep transcripts under standard growth conditions. Several
other cis-encoded sRNAs expressed by S. aureus were detected in
mobile genetic elements (PIs, plasmids, transposons) that are
complementary to mRNAs expressing transposases involved in
genome plasticity and integrity. RsaOX is complementary to the
coding sequence of the SA0062 mRNA encoding a putative
transposase [11]. Another transposase, IS1181, is probably also
regulated by two additional sRNAs, RsaOW/Teg17 and Teg24as,
which are complementary to its 59 UTR, including a portion of
the Shine Dalgarno (SD) sequence, and also to the 39 UTR
[10,11]. In strain N315, the gene encoding the transposase is
repeated eight times and these two sRNAs are systematically
detected on the tnp locus [10]. Cis-encoded sRNAs can also
interact with additional mRNA targets at distant genetic loci, in
trans.
Trans-encoded sRNAs
In contrast to the cis, the trans-encoded sRNAs are transcribed at
distant genetic loci from their molecular targets and share only
partial and often interrupted pairing complementarities, as for the
eukaryotic microRNAs (Figure 1B). Although a seeding interaction
of six to seven nucleotides is sufficient to initiate the ‘‘sRNA–
mRNA’’ interaction in E. coli [19], pairings are usually much
longer for the sRNAs expressed by S. aureus, probably due to its
AT-rich genome. In most cases, the interaction involves the 59
domains of the sRNAs that encompass the translation initiation
signals (TIS) of the mRNA targets [20]. Conserved and accessible
motifs were detected in several S. aureus sRNAs containing
consensus sequences involved in the initial pairing with their
Figure 1. A variety of mechanisms of actions for the S. aureus sRNAs. (A) Cis-encoded sRNAs bind via perfect complementarities with mRNA
targets at the translation initiation sequence, preventing ribosome binding and therefore translation. (B) Trans-acting sRNAs. The trans-encoded
sRNAs bind and block the ribosome binding site by interrupted pairings, using one or two hairpin(s) to repress translation initiation. (C) Cis-encoded
antisense sRNAs acting in trans. In the SprA1/A1AS TA module, SprA1AS prevents SprA1 translation to prevent toxic peptide expression. On the two
interacting sRNAs, the cis and trans pairing-regions are indicated in blue and red, respectively.
doi:10.1371/journal.ppat.1003767.g001
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target mRNAs. Several sRNAs from the Rsa family contain
unpaired and accessible UCCC motives located in conserved
hairpin regions of the sRNAs predicted to interact with the target
mRNA translation initiation signals [12]. The RNAIII also
harbors several UCCC motifs in the three loops H7, H13, and
H14, which interact with the SD sequences of several target
mRNAs. These UCCC motives were also detected in sRNAs
expressed from other gram-positive bacteria such as L. monocytogenes
and B. subtilis [21–24]. Accessible C-rich boxes could be a general
signature of regulatory RNAs controlling translation initiation of
various target mRNAs.
Cis-encoded antisense sRNAs acting in trans
Type I Toxin/Antitoxin (TA) pairs are present on plasmids or
chromosomes, or both simultaneously [25], and consist of stable
toxins and labile antitoxins encoded within small genetic modules.
In S. aureus, several candidates of type I TA were detected based
on sequence homology [26], among which are SprA1/A1AS and
the SprG/F modules. SprA1-SprA1AS is an RNA pair transcribed
from a pathogenicity island, a genetic element acquired by
horizontal transfers. SprA1 is a stable and structured 208 nt-long
RNA that contains an internal open reading frame (ORF)
encoding a cytolytic peptide, pepA1 [27]. PepA1 inserts within
the biological membranes, alters their integrity, and induces cell
death [28]. A small cis-antisense RNA of SprA1, named SprA1AS
(Teg152, [10]), is transcribed from the complementary DNA
strand. Although 35 nt at SprA1AS 39-end are perfectly comple-
mentary to a sequence located at SprA1 39-end, SprA1AS acts in
trans by base pairing with the 59 domain of SprA1 to repress pepA1
translation by occluding the TIS, preventing its toxicity for the
bacteria (Figure 1C). By analogy, the SprA2/A2AS pair, consid-
ered as a second copy due to elevated sequence identity with
SprA1/A1AS, may also act in trans. Another unconventional case
of a cis-trans RNA was detected in a plasmid from Enterococcus
faecalis, another gram-positive bacterium, within the par stability
determinant of a plasmid required for stable inheritance in its host
[29]. In that case, overlapping RNAs I and II share a bidirectional
transcription terminator but interact with one another by two non-
overlapping direct repeats.
sRNAs with Multiple Functions
SsrA/tmRNA responsible for trans-translation and acting
as a trans-RNA
Transfer-messenger RNA (tmRNA or SsrA) is an sRNA
expressed in all bacteria that displays both tRNA and mRNA
properties. tmRNA, with the help of the SmpB protein, governs
trans-translation, a process that rescues the ribosomes stalled
during translation of defective mRNAs, such as those lacking in-
frame termination codons [30,31]. tmRNA is recruited by the
ribosomes through the smpB protein, an essential participant for
ribosome rescue, and acts first as transfer RNA (tRNA) to add an
alanine to the stalled polypeptide chain. Translation then switches
from the problematic mRNA to a short tmRNA internal ORF that
encodes a proteolytic tag [32,33]. The stalled ribosome is released
at the tmRNA termination codon, and the problematic mRNA
and the tagged protein are degraded by specific RNAses and
proteases, respectively. Trans-translation allows ribosome recy-
cling and degradation of potentially toxic truncated mRNAs and
proteins. A recent study [34] showed that tmRNA activity in S.
aureus was not restricted to trans-translation. Inactivation of ssra-
expressing tmRNA leads to an increase of pigment synthesis that is
counteracted by expressing a tmRNA harboring a mutated tag.
Furthermore, this phenotype is not imputable to the alteration of
trans-translation since SmpB inactivation did not modify the
quantity of pigments produced by S. aureus. The phenotype is due
to the overexpression of the crtMN operon which encodes two
enzymes involved in pigment synthesis. As the tmRNA sequence
displays partial complementarity with the 59 UTR of the crtMN
mRNA, it could also act as an antisense sRNA acting in trans to
regulate crtMN mRNA translation [34].
RNAIII, the Paradigm
RNAIII is the effector of the agr quorum-sensing system which
coordinates gene expression in S. aureus according to the local
density of bacteria [35]. The agr locus is transcribed from two
divergent promoters, P2 and P3. Four genes (agrA, B, C, and D) are
expressed as an operon from the P2 promoter, and RNAIII is
transcribed from the P3 promoter [35]. An autoinducing peptide
(AIP) is produced from agrD and secreted in the extracellular
medium. The AIP binds to the agrC transmembrane protein,
which, in turn, activates the agrA response regulator. AgrA, in
conjunction with the global regulator SarA, activates transcription
of its own operon and that of RNAIII. RNAIII controls the switch
between early expression of surface proteins and late production
of S. aureus exotoxins. RNAIII represents a paradigm in the field
of bacterial RNAs exerting influence on pathogenesis. RNAIII
controls target gene expression at multiple levels, including
transcription, translation, and mRNA stability. RNAIII regulates
by antisense pairings, at the post-transcriptional level, the
expression of numerous targets involved in virulence and cell wall
metabolism. RNAIII represses the expression of hydrolases and
amidases involved in peptidoglycan turnover, an effect occurring
at high cell density when RNAIII accumulates. RNAIII is a
514 nt-long RNA that possesses an intricate fold [36], is composed
of 14 stem-loops (H1-H14) and three long-distance helices, and
meets the definition of a multifunctional, ‘‘all-in-one’’ RNA.
It encodes internally the d-hemolysin peptide, which displays
hemolytic and microbial activities [37–39]. Through various
structural domains, RNAIII acts as both an activator and a
repressor of dedicated mRNA targets. As for several trans-acting
sRNAs, RNAIII coordinates complex regulatory networks.
RNAIII activates translation of the hla mRNA encoding the a-
hemolysin [40]. In the absence of RNAIII, the 59-end of the hla
mRNA forms a structure that blocks access to the ribosome on
the Shine-Dalgarno (SD) sequence. RNAIII, via hairpins H2 and
H3, interacts with the 59UTR of the hla mRNA and provides
accessibility to the SD site and, consequently, triggers a-hemolysin
translation. RNAIII also up-regulates MAP production by
interacting with the map mRNA via antisense pairings [41].
MAP, also named Eap (Extracellular adherence protein), is a
surface adhesion protein involved in S. aureus immune evasion
[42]. The mechanism of regulation, however, remains to be
elucidated. On the other hand, RNAIII inhibits translation of
various target genes by pairing at the TIS of several target mRNAs
to inhibit their translation and trigger their degradations. In some
cases, a single loop binding is not sufficient for down-regulation,
and RNAIII binding requires additional interactions at the vicinity
of the initial binding site [43,44]. RNAIII represses translation of
the SA1000 mRNA expressing a fibrinogen-binding protein
involved in S. aureus adhesion to epithelial cells, of SA2353 mRNA
producing a secreted antigen precursor [43], of spa mRNA
encoding the immune escape protein A [14], of coa mRNA
encoding a coagulase [43,44], as well as of rot mRNA encoding a
transcription factor repressing toxin production [43,45]. Several
proteins that are regulated by RNAIII are major virulence factors
produced by the S. aureus clinical isolates during infection. The
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influence of RNAIII on membranes, surface proteins, and cell wall
turnovers contributes to virulence by controlling nutrients’ entries
and host defences, struggle, and resistance by regulating hemoly-
sins production and host immune evasion. We expect that RNAIII
possesses additional targets involved in S. aureus virulence control,
which will be progressively identified by high throughput methods
using Deep RNA sequencing technologies combined with target
affinity purifications.
Proteins Involved in S. aureus sRNA Functions
Hfq: A controversial factor
Since trans-encoded sRNAs display short and imperfect com-
plementarity to their target mRNAs, the effective sRNA-mRNA
annealing requires an auxiliary factor in some bacterial species.
Hfq, a member of the conserved RNA-binding Sm-like protein
family, is needed for the efficient annealing of some sRNAs to
target mRNAs and for the intracellular stability of these sRNAs. In
the case of canonical sRNA, the Hfq protein enhances the binding
of sRNA on the translational start site of their mRNA targets and
prevents ribosome binding. Hfq is only active in its multimeric
form. The Hfq ring formed by homohexameric Hfq proteins
displays a characteristic doughnut-shaped structure containing two
single-stranded RNA-binding faces located on opposite sides of the
ring. The proximal face binds to AU-rich sequences and sRNAs,
whereas the distal face interacts with poly(A) sequences [46,47].
The dual RNA-binding surface allows the simultaneous recruit-
ment of an sRNA and its mRNA target on one Hfq molecule. Hfq
facilitates sRNA–mRNA interaction by increasing the local
concentration of the RNA species and/or by enhancing the base
pairing interaction through a restructuring of these RNAs. In E.
coli, the chaperon Hfq affects the turnover of some target mRNA
by recruiting an RNase E in an activated state on the sRNA–
mRNA duplex [48,49]. The requirement of Hfq for riboregula-
tions by trans-encoded sRNAs depends on the small RNAs,
mRNAs, and the bacterial species. Potential links between the free
energy for sRNAs–mRNA pairing, the GC-content of the bacterial
genome, and the involvement of Hfq protein have been proposed
[50]. A highest DG value and a lowest GC-content correlate with a
dispensability of Hfq protein for the sRNAs–mRNAs pairing.
Accordingly, Hfq is required in sRNAs regulations, which are
involved in the growth, the sensitivity to various environmental
stresses, and the virulence of several gram-negative strains.
Moreover, Hfq or Hfq-like proteins are absent in several ‘‘low
GC’’ gram-positive strains such as Streptococcus pneumoniae and
Lactococcus lactis. In S. aureus, the function of Hfq remains unclear.
Inactivation of the hfq gene in three S.aureus strains (RN6390,
COL, and NEWMAN) did not affect the phenotypes of these
strains [51]. In S. aureus, Hfq was not involved in more than 2,000
phenotypes tested, including sensitivity to different stress condi-
tions, antibiotic sensibility, and virulence [51]. In agreement with
the Hfq dispensability in the riboregulation, the protein has no
effect on the stability/turnover of several trans-acting sRNAs
[12,27,43,45,52,53]. The S. aureus Hfq does not enhance the
binding of RNAIII to spa mRNA or SA1000 mRNA, whereas an
Hfq-RNAIII complex from RN6390 cells co-immunoprecipitates
with an antibody against Hfq [43,52]. However, Hfq seems to
be functional in S. aureus, since the overexpression of Hfq in an
agr2 strain leads to the stimulation of the c-haemolysin
translation. This discrepancy between the ability of Hfq to tightly
bind RNA in vitro and its inability to affect the riboregulation in
vivo could be explained by the very low expression levels of Hfq
in the laboratory-adapted strains RN6390 and COL. Indeed,
inactivation of the hfq gene in the S. aureus 8325-4 strain expressing
a detectable Hfq level alters the expression profiles of 116 genes
potentially involved in the decrease of the pathogenicity of the
muted strain in a murine peritonitis infection model and in the
increase of expression of the surface carotenoid pigment [54].
The relationship between Hfq and carotenoid production was
also revealed in another S. aureus strain. Low-fluid-shear culture of
N315 cells, which promotes attachment-independent biofilm
formation, leads to a decrease of carotenoid production associated
with a down-regulation of the Hfq protein [55]. Hfq specifically
binds to 49 of the 116 genes down-regulated in the hfq mutant of
S. aureus 8325-4. In particular, some mRNA targets of sRNAs,
such as sbi, sucD, and rot for respectively SprD, RsaE, and RNAIII,
were copurified with Hfq, suggesting that Hfq could be implied
in the translational regulation of some S. aureus genes [54].
Altogether, these studies show that the modulation of virulence
and stress response could be attributed to Hfq in some strains.
However, the direct involvement of sRNAs in these Hfq-
dependent phenotypes and the mechanisms of actions of potential
‘‘sRNA/Hfq’’ complexes remain unknown. As S. aureus does not
express RNase E, Hfq could recruit another endoribonuclease to
affect the turnover of mRNA targets. Hfq proteins from different
bacteria contain an evolutionarily conserved core of 65 amino
acids and a divergent positively charged C-terminal end. The C-
terminus extensions are short in gram-positive bacteria (like S.
aureus, B. subtilis, and L. monocytogenes) and longer in gram-negative
bacteria (102 amino acids in E. coli and Salmonella). Recently the C-
terminal extension of E. coli Hfq protein was shown to be required
for a non-canonical sRNA pathway, a translational regulation
involving the binding of sRNA outside the canonical ribosome
entry site, probably by recruiting additional RNAs or proteins on
the mRNA target [56]. Thus, the short C-tail extension mainly
present in S. aureus could be involved in the recruitment of specific
ligands during the Hfq-dependent riboregulation by non-canonical
sRNAs. In S. aureus strains that do not express the protein, the role
of Hfq might be superseded by other RNA-binding molecules.
RNAse III: The major RNase involved in the sRNA-
dependent mRNA turnover
Staphylococcus aureus RNase III belongs to the family of Mg2+-
dependent endoribonucleases which cleave double-stranded RNA
to generate short RNA duplexes with a 59 phosphate group
and two nucleotides 39-overhang. The enzyme contains a catalytic
and a dsRNA-binding domain and functions as a homodimer to
recognize and cleave a variety of structures including imperfect
duplexes, loop–loop interaction, and stacked helices [57]. Histor-
ically described as an endoribonuclease involved in rRNA
processing and maturation in E. coli and B. subtilis, the enzyme
also participates in the regulation of single and polycistronic
mRNA as well as in the processing of some housekeeping RNAs in
B. subtilis [58,59]. In S. aureus, the RNase III-processing alone
enhances mRNA stability and translation of the major cold-shock
CspA protein through a cleavage within the 59 leader and
autoregulates its synthesis by initiating the degradation of its own
mRNA [60]. In contrast with the essential involvement of the
endoribonuclease RNase III in the viability of E.coli and B. subtilis,
the enzyme does not influence the growth of S. aureus, but plays
an important role in the pathogenicity of S. aureus in murine
models [61]. RNase III is involved in the mRNA turnover of some
trans-acting sRNA targets. In S. aureus the enzyme acts as an
essential co-factor of the quorum-sensing regulatory RNA III for
the irreversible translational repression of the mRNAs coding
for the protein A (spa), the staphylocoagulase (coa) [44] and the
transcriptional regulator Rot [45]. The enzyme interacts with
RNAIII without promoting the repressor activity of RNAIII by
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improving the stability of RNAIII–mRNA duplexes. RNAse III
only cleaves RNAIII when the sRNA is bound to its mRNA
targets [52,62]. RNAIII binds to the ribosome binding site of coa
and rot mRNAs and recruits RNase III, which cleaves the mRNA
target at an equivalent position of the loop–loop pairing. The
RNase III cleavage site is independent of the sequence of the base
pairs. The loop–loop interaction forms a unique hairpin motif
creating a single binding site for the RNase III, which leads to a
specific cleavage at single positions of the kissing interactions and
irreversible repression of mRNA translation [62]. Several RNase
III-binding sRNAs were identified by deep sequencing of RNA
coimunoprecipitated with a wild-type RNase III and/or cleavage-
defective mutants in vivo. Among the 58 sRNAs detected, many
have been previously identified, such as the pathogenicity island-
encoded small RNAs SprA, SprA3, SprB, SprC, SprF3/G3 [15],
and RsaA, RsaE, RsaH, RsaI, RsaJ [11,12], as well as RNAIII.
Some of these sRNAs were copurified with the cleavage-defective
mutant and display hairpin motifs recognizable by the enzyme,
suggesting that there are substrates of RNase III [60,62]. Thus,
it appears that most of these known and unknown sRNAs are
potential trans-acting factors which regulate gene expression by
antisense mechanisms and recruit RNAse III to direct the mRNA
decay. Also, RNase III could mediate specific cleavage of type I
toxin/antitoxin pairs (SprA1/SprA1AS, SprG/SprF) to prevent
toxic peptide expression. RNase III is associated with a large
number of antisense transcripts, covering 44% of the annotated
genes [60,63]. These antisense (as) RNAs are issued from a
genome-wide process of overlapping transcription and are
perfectly complementary to the 59 ends, 39 ends, middle, or entire
genes or operons [5,60,64]. RNase III-associated cis-asRNAs are
usually expressed at lower levels than their complementary
mRNAs, and they direct the degradation of residual mRNAs.
The RNase III-mediated digestion of sense/antisense transcripts
generates a large collection of short, 22 nucleotide-long, double-
stranded RNAs that could also have functions [64]. Pervasive
transcriptions lead to the expression of RNase III-associated
mRNAs, which overlap at their 59 or 39 UTRs. RNase III-induced
cleavages of the 59 overlapping regions of divergent mRNAs allow
the fine regulation of the expression of genes which have to be
expressed in a coordinated manner as the tagG/tagH teichoic
acid biosynthetic genes encoding the TagGH ABC transporter
complex [60,63]. These cleavages generate mRNAs with shorter
59ends which could be more sensitive to degradations and/or
influence their translations. In some cases, the 59 UTRs of mRNAs
extend into the coding sequence of their neighbouring genes [64].
Similar large asRNAs are encoded at particular genomic loci
called the ‘‘excludons’’ in the gram-positive Listeria monocytogenes
[65]. These long asRNAs span divergent genes or operons with
related or opposing functions, and allow meticulous regulatory
switches in bacteria [66], probably also occurring in S. aureus. In
S. aureus, the activity of RNase III, in association with large
asRNAs, could be considered a general mechanism to regulate
and coordinate the expression of neighbouring genes.
Other RNases: RNase J1-J2 and RNase Y
In E. coli, sRNA-mediated mRNA decay mainly involves the
recruitment of RNase E on the mRNA target. The RNase E is
the central component of the degradosome that is composed of a
39-exoribonuclease polynucleotide phosphorylase (PNPase), a
RNA helicase (RhlB) and a glycolytic enzyme (enolase). RNase
E catalyzes the initial endoribonucleolytic cleavage of mRNA
targets which is followed by a directional, 39 to 59, degradation by
the PNPase with the help of RhlB [67]. Most gram-positive
bacteria do not contain an RNase E and use RNase E functional
orthologs and other degradosome components to direct mRNA
decay. Both S. aureus and B. subtilis contain a similar multicom-
ponent ribonucleolytic degradosome complex formed around
RNase Y, a functional homologue of RNase E [4,68]. The S.
aureus degradosome includes both RNases J1/J2 originally
proposed to act also as functional orthologs of RNase E [69],
the PNPase, the enolase, the RNA helicase CshA, and RNase P
[4]. The CshA Dead-box RNA helicase plays an essential role in
the regulation of quorum sensing by controlling the agrBDCA
mRNA turnover [70,71]. Both RNases Y and J1, which exhibit
RNase-E–like 59 end-dependent endonucleolytic activity, play a
central role in the degradation of mRNAs in B. subtilis. The
endonucleolytic cleavage by the RNase Y initiates the mRNA
decay, and the resulting RNA fragments are likely to be degraded
by the 59-39 exoribonuclease activity of RNase J1 and by the 39–59
activity of PNPase [72,73]. In contrast to B. subtilis, the membrane-
associated RNase Y of S. aureus is not essential for growth but
is required for virulence [74,75]. The enzyme is involved in the
processing of the global virulence regulator sae and in the
expression of various virulence genes by an indirect mechanism
[75]. The RNase Y controls the stability of specific mRNAs and
sRNAs. Interestingly, inactivation of the rnc gene encoding for
RNase Y in S. aureus results in an increase of the half-life of two
sRNAs, RsaA and Sau63 [8,12], whereas the RNAIII steady-state
level is unaffected. The specific activity of RNase Y represents a
way to control both the expression of sRNAs and their mRNA
targets in S. aureus. A similar regulation was detected in E.coli,
where RNase E specifically affects the steady-state level of several
sRNAs [59]. In contrast with the activity of RNase E in E. coli, an
implication of RNase Y in the coupled degradation of sRNAs and
their mRNA targets has not been revealed.
sRNAs Involved in Stress Response, Metabolisms,
and Regulatory Networks
Sigma B-inducible small RNA encoding genes
The pathogenicity of S. aureus depends on its ability to respond
quickly and specifically to a variety of environmental stresses and
to control virulence genes expression. The S. aureus genome allows
expression of the alternative sigma B transcriptional factor (sB)
that is an essential part of the complex regulatory network
controlling the expression of around 200 genes involved in
virulence, cell wall metabolism, and membrane transport processes
[76–78]. sB is involved in stress responses and contributes to
pathogenesis in animal models of infections [79]. The S. aureus
sigma B operon resembles that of the homologous B. subtilis
operon. It contains sB, an anti-sB factor RsbW, an anti-anti-sB
factor RsbV, and RsbU, a Mn2+-dependent phosphatase that
positively controls sB activity by dephosphorylating RsbV [80,81].
The sigma B regulon includes genes directly up-regulated by sB
and genes indirectly regulated via sB-dependent expression of
regulatory factors such as the SarA transcription factor [76,77]. In
particular, the inactivation of sB has an indirect impact on the agr
quorum-sensing system by enhancing RNAIII expression [82]. By
computational approaches based on the search for sB consensus
binding sites (GWWT_N14–17GGGWWW) and transcriptional
terminator sequence within the intergenic regions of S. aureus strain
N315, three sB-regulated genes coding for new sRNAs were
identified and validated [53]. Two of these sRNAs, SbrA and
SbrB, are highly conserved among Staphylococci (for sB-dependent
small RNAs A and B) and encode putative basic peptides of 26 and
38 amino acids, which are potential virulence factors. In contrast
to sbrA, the peptide from sbrB gene is translated only in some S.
aureus, whereas SbrB is expressed in all strains, which suggests a
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potential dual function of SbrB: a peptide-coding sRNA and
activity as an sRNA regulator [53]. The third sRNA, SbrC, is a
potential cis-acting antisense targeting the 39 end of the mntABC
operon encoding for an ABC transporter dedicated in the uptake
of manganese. The manganese acquisition is crucial for defence
systems against oxidative stress and contributes to the virulence of
S. aureus [83]. In S. aureus, sB-dependent transcription is induced
by the presence of MnCl2, probably via the stimulation of the
Mn2+-dependent phosphatase activity of RsbU [77]. The sB-
dependent induction of SbrC could be a way for sB to
autoregulate its own activity and to modulate manganese uptake
in function of Mn availability. The transcription of other sRNAs
like RsaA, RsaD, and RsaF is induced in S. aureus strains
expressing an active sB factor [12]. These sRNAs are differently
transcribed in response to environmental stresses such as oxidative
stress, heat stress, cold stress, osmotic stress, and acidic pH. A
conserved sB promoter sequence was found upstream rsaA,
suggesting its direct regulation by the sB. As RsaA is a trans-
acting regulator that potentially targets three mRNAs repressed by
sB [12,76,77], it could be an intermediate in the regulatory
network controlled by sB.
Metabolisms regulations
In S. aureus, all macromolecules are synthetized from 13
biosynthetic intermediates produced by glycolytic, pentose
phosphate, and tricarboxylic acid cycle (TCA cycle) pathways.
These three central metabolic pathways are closely linked to
the expression of several virulence factors. The alteration
of pentose phosphate and glycolytic pathways affects the
quorum-sensing–dependent regulation of RNAIII [84,85], and
TCA cycle inactivation induces a reduction in the production of
several secreted virulence factors and cell-associated adhesion
factors [86,87], thus, slowing down central metabolism reduces
bacterial virulence. Recently, RsaE, a sRNA conserved in all S.
aureus strains, and also in firmicutes, has been shown to regulate
several metabolic pathways [11,12] (Figure 2). The overexpression
of RsaE induces a growth defect that is partially alleviated by the
addition of acetate, arguing for a role of RsaE in both catabolisms
and anabolisms. Indeed, RsaE down-regulates the synthesis of
enzymes from the TCA cycle (succinyl-Coa synthetase sucC
and sucD, aconitase (citB), citrate synthase (citZ), and isocitrate
dehydrogenase (citC)), and from the folate-dependent one-carbone
metabolism (bi-functional protein fold and the formate-tetrahy-
drofolate ligase (Fhs)), which is involved in the purine biosynthesis
pathway. RsaE also affects the amino acid pool in S. aureus. It up-
regulates the expression of valine, leucine, and isoleucine operons
and potentially alters aspartate biosynthesis by inducing the
expression of pyruvate carboxylase. Moreover, RsaE down-
regulates the opp-3 operon coding for an oligopeptide transporter
involved in the uptake of specific peptides and in the regulation
of extracellular protease production [88,89]. As the transcription
of genes encoding for some enzymes of the TCA cycle is regulated
by the availability of amino acids [90], RsaE could indirectly
modulate the TCA cycle via the regulation of the pool of free
intracellular amino acids. The distinction between metabolic
pathways directly and/or indirectly regulated by RsaE is difficult
to apprehend because these pathways are highly interconnected.
RsaE can directly regulate the TCA cycle and amino acid uptake
Figure 2. RsaE controls central metabolic pathways. RsaE regulates, directly or indirectly, the expression of several genes involved in amino
acid synthesis, peptides transport, carbohydrate metabolism, and the TCA cycle. RsaE directly regulates the TCA cycle by inhibiting sucD mRNA
translation coding for one of the subunits of the succinyl-Coa synthase. It alters the purine biosynthetic pathway via the down-regulation of some
enzymes involved in the folate-dependent, one-carbon metabolism. RsaE uses multiple binding sites for the regulation of the opp3BCDFA mRNA
expressing an oligopeptide transporter involved in nutrient transport. RsaE pairs directly with sites overlapping the ribosome binding site of the
upstream (opp3B) and distal (opp3A) genes from the operon to inhibit their translations. RsaE modulates the intracellular pool of amino acid by down-
regulating the expression of an oligopeptide transporter and by up-regulating genes that produce amino acid synthesis enzymes. In some S. aureus
strains, RsaE expression is controlled by the agr quorum-sensing system in response to autoinducing peptide (AIP), and it depends on the sB regulon.
The plain and dashed lines indicate the direct and indirect gene regulations, respectively (red bars: inhibitions, black arrows: stimulations).
doi:10.1371/journal.ppat.1003767.g002
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by inhibiting the formation of ribosomal initiation complex on
sucD and opp3A/opp3B mRNAs, respectively [11,12]. The TCA
cycle is involved in the energetic transition which uses the acetate
accumulated in the extracellular medium during the glycolysis
and amino acids as an alternative carbon source. Although the
expression profile of RsaE is a subject of controversy [11,12], in
some S. aureus strains, RsaE is expressed at late exponential phase
and repressed at stationary phase, and it could facilitate the
transition of energy metabolisms, the purine biosynthesis, and
amino acid transport in response to the nutrients’ availability.
Moreover, the RsaE expression seems to be dependent on the agr
quorum-sensing system and sB activity, suggesting that it could
modulate the metabolism profile in function of stress responses
and/or virulence [12].
sRNAs involved in global regulatory networks
S. aureus expresses a large array of extracellular and cell-wall–
associated virulence factors at different stages of the infectious
process. The exoproteins and cell-wall–associated adhesins,
respectively involved in host immune evasion and host cell
adhesion, are expressed early during the initial colonization, while
the production of toxins that facilitate S. aureus growth and spread
in the host tissues occurs late during infection. Their temporal
expressions are controlled by two component regulatory systems
(e.g. saeRS, arlRS, lytSR, srrAB) and global transcriptional
regulatory factors (e.g. the sarA protein family, spX). The
overlapping regulation between two component systems and
global transcriptional factors constitutes a fine-tuning system for an
efficient transcriptional control of virulence genes expression [91].
These factors affect the expression of virulence genes by directly
binding to the promoters of target genes and/or indirectly through
the regulation of the expression of global regulatory elements
targeting the same set of virulence genes. RNAIII has character-
istics similar to global regulatory factors that regulate directly and
indirectly the expression of virulence genes, such as spa and hla
genes [14]. The expression of spa encoding an adhesin acting as
an host immune evasion protein is directly controlled, at the
translational level, by an ‘‘RNAIII-mRNA’’ direct pairing
mechanism [14], as well as at the transcriptional level by three
members (SarA, SarS, and Rot) of the SarA family of transcrip-
tional regulators (Figure 3) [92]. spa is positively regulated by the
transcriptional factors Rot (Repressor of toxins) and SarS and
negatively regulated by SarA. RNAIII affects the mRNA level of
spa by inhibiting rot translation by a base pairing mechanism [45].
As Rot activates SarS transcription, RNAIII-mediated inhibition
of Rot expression down-regulates the two transcriptional activators
of spa. These transcriptional and translational controls avoid
putative leakages in spa mRNA expression. RNAIII uses similar
double controls to up-regulate the expression of hla encoding the
a-hemolysin [93]. RNAIII enhances a-hemolysin translation by
a pairing interaction at hla mRNA 59UTR [40] and up-regulates
hla mRNA expression by down-regulating Rot, which acts as a
repressor of hla transcription in SaeRS- and SarS-dependent ways
[93,94]. In accordance with the antagonism between Rot and
RNAIII, cellular amounts of Rot are inversely correlated to
the RNAIII level in most S. aureus strains [95]. However, the
transcriptomes of S. aureus strains deleted in RNAIII or in Rot only
partially overlap, suggesting that RNAIII affects the expression
levels of additional transcription factors [96]. One potential target
of RNAIII could be the transcriptional factor SarT, which is
down-regulated by agr at the post-exponential phase of growth
[97] and contains a putative pairing interaction with RNAIII at
its 59UTR [43]. RNAIII-mediated down-regulation of SarT,
which acts as a positive and negative transcriptional regulator of
sarS and hla, respectively, could be another way to control spa and
hla expression. The involvement of S. aureus sRNAs in the global
gene regulatory network is not restricted to RNAIII. Recently, a
new sRNA named ArtR (AgrA-repressed, toxin-regulating sRNA)
was reported to activate a-hemolysin expression by binding to the
sarT mRNA, promoting its degradation [98]. Although RNAIII
and ArtR both similarly regulate hla expression, they display
different expression patterns. In contrast to RNAIII, ArtR
transcription is repressed by agrA, suggesting that ArtR-mediated
hla up-regulation could be enhanced in agr-deficient strains.
Multiple sRNAs controlling the expression of a similar compo-
nent from a regulatory network allows the sharp regulation of
virulence genes. Given the importance of multiple components
from regulatory networks to express virulence genes and the
elevated variability of their expression levels among the S. aureus
strains, it is most likely that S. aureus expresses many other sRNAs
that deeply interact with this network to influence bacterial
virulence.
Figure 3. Schematic overview of the multiple interactions
between sRNAs and transcriptional regulators involved in spa
(protein A) and hla (a-hemolysin) expression in S. aureus strain
8325-4. The arrows indicate the stimulations and the bars, the
repressions. The direct effects of two sRNAs on gene expression are
indicated in red. RNAIII represses rot and spa translation by direct pairing
interactions [14,45]. Rot requires SarT to stimulate SarS in the presence of
SarA [92,120]. In contrast to SarA, Rot and SarS are direct activators of spa
expression [92,121]. In the exponential phase of growth, spa transcrip-
tion is stimulated by Rot and by SarS. In the post-exponential phase, spa
transcription and translation are repressed by SarA and RNAIII,
respectively, and the direct inactivation of Rot by RNAIII leads to the
repression of the Rot and the SarS-dependent transcription activations
of spa. hla is up-regulated by SarA and down-regulated by SarS [93]. Rot
and SarT repress hla transcription by a sae-dependent way [94]. In the
post-exponential phase of growth, RNAIII enhances hla translation by
direct pairings at the hlamRNA 59UTR and stimulates hla transcription by
down-regulating the expression of SarT and Rot. AgrA, the master
transcriptional regulator of quorum sensing, stimulates RNAIII expres-
sion [122] but also represses ArtR expression. ArtR indirectly activates hla
transcription by repressing sarT translation [98]. SarA stimulates the
AgrA-dependent expression of RNAIII [122]. SarT directly represses SarU
which activates agr (RNAIII) transcription [123].
doi:10.1371/journal.ppat.1003767.g003
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sRNAs and Virulence Gene Regulations
The dual-function SCCmec-encoded psm-mec RNA
suppresses agrA translation and attenuates MRSA
virulence
SCCmec is a mobile genetic element that confers methicillin
resistance to the methicillin-resistant S. aureus (MRSA) strains.
SCCmec contains several genes, including the cytolysin psm-mec
gene, whose transcription product suppresses colony spreading
and the expression of phenol-soluble modulin a, a cytolytic toxin
[99]. The psm-mec RNA binds the agrA mRNA, encoding a
virulence regulatory factor and inhibits its translation [100].
Deletion of psm-mec in MRSA clinical isolates increases virulence
on mice skin infection models (Figure 4). The psm-mec RNA
suppresses MRSA virulence by agrA translation inhibition, and
the absence of psm-mec in community-acquired (CA) MRSA strains
is responsible for their elevated virulence.
SprD, a pathogenicity island-encoded RNA regulating an
immune-evasion molecule from the core genome
Small pathogenicity island rNA D9 (SprD) is among the few S.
aureus RNAs with an identified function. SprD is expressed from
the genome of a converting phage [15], a horizontally-acquired
pathogenicity island (PI) being the repository of toxins, adherence,
invasion factors, superantigens, and secretion systems [101]. SprD
down-regulates, at the translational level, the expression of the
Sbi immune evasion molecule located on the core genome [102].
One of its four hairpins binds the 59 UTR of the sbi mRNA by
an antisense pairing mechanism. The initial binding involves the
hairpin loop, and the interaction extends farther upstream and
downstream from that initial binding site. The ‘‘SprD-sbi mRNA’’
interaction sequesters the sbi mRNA TIS and, consequently,
prevents translation initiation of the Sbi protein. Sbi is an
immunoglobulin-binding protein expressed by S. aureus [103] that
impairs the host immune response. Sbi acts as a complement
inhibitor and forms a tripartite complex with host complement
factors H and C3b [104]. SprD contains four hairpins, one of
which interacts with the ribosome binding site of sbi mRNA to
form a long imperfect duplex that prevents translation initiation in
vivo. SprD contributes to causing disease in a mouse model of
infection, although this effect is not only linked to the deregulation
of Sbi production. It suggests that SprD regulates the expression of
other targets playing important roles during host infection.
The implication of the 891 nucleotides-long small stable
RNA42 in S. aureus virulence
Small stable RNAs (SSRs) are RNAs specifically produced and/
or stabilized in response to various environmental conditions
[104]. Among the SSRs, SSR42 is involved in host erythrocyte
lysis, resistance to human polymorphonuclear leukocyte killing,
and pathogenesis in a murine model of bacterial infection [3].
SSR42 is primarily expressed during the stationary phase of S.
aureus growth, is a stable RNA with a ,30 minute half-life, and
appears to control the expression of a large set of target genes
(,80) including virulence factors, which is the rationale of its
involvement in S. aureus pathogenesis and virulence.
sRNAs Expressions during Infections
Staphylococcus aureus is a common resident of human skin and
nasopharynx. It is also a cause of life-threatening illness, producing
virulence factors that enable survival and spreading in various
hosts. Its switch from commensalism to an infectious pathogen is
poorly understood, whereas nasal carriage and clinical isolates
belong to the same genetic clusters [105]. The few S. aureus sRNAs
with known targets regulate major biochemical pathways, some
ultimately implicated in virulence [6]. The S. aureus sRNAs were
detected and studied in various strains and their specific expression
profiles during infection in humans are, for the vast majority of the
,250 sRNAs expressed by this bacterium, unknown. However,
RNAIII expression in clinical samples, such as nasal secretions or
cystic fibrosis sputa, has been monitored [106–108]. The majority
of clinical isolates isolated from acute infections has functional agr
and produces RNAIII in vivo [109]. These data suggests that
RNAIII influences the virulence phenotype. Agr-defective mu-
tants, however, were detected in infected patients, and a mixture of
agr positive and defective strains were detected in healthy humans
[110]. Thus, agr is involved during acute infection, while agr
mutants can be selected during chronic infections and dormant
states. A recent study reported the expression profiles of the five
sRNAs (RNAIII, RsaA, RsaE, RsaG, and RsaH) in strains isolated
from patients with acute cutaneous infection, chronic cystic
fibrosis, or nasal colonization [111]. The expression profiles of
these five sRNAs are strain-specific and do not correlate to the
type of infections or colonization, but the authors noticed that
sRNA expression was more uniform among the strains from
colonization compared to those responsible for infections. This
observation might reflect the fact that S. aureus was primarily
a commensal and then became an opportunistic pathogen
[112,113]. Deep RNA sequencing technologies now allow global
analyses of the S. aureus RNome in various clinical isolates to detect
putative differences of expression of all sRNAs, with possible
applications in the early diagnostic of strains that are susceptible to
cause life-threatening infections.
Phenotypes Associated with sRNAs Expressions
sRNAs can be differentially expressed in ‘‘normal’’ versus ‘‘small-
colony variant’’ (SCV) phenotypes, as identified in a S. aureus clinical
strain recovered from a patient with osteomyelitis [8]. SCVs grow
slowly, lose their pigmentations, have reduced hemolytic activity,
have decreased susceptibility to aminoglycosides, have lower toxins
production, and have improved intracellular persistence [112,114–
117]. The ‘‘normal’’ phenotype corresponds to the ‘‘virulent’’
strain, whereas the SCVs are persister cells. In SCVs, the expression
of RNAIII is phenotype-specific, detected in the normal phenotype
but switched off in the SCVs [8]. The absence of RNAIII in
the SCVs may account for their decreased output of toxins and
their lower virulence [115]. Moreover, the expression of several
pathogenicity islands (PIs)-encoded sRNAs, sprA-G, is turned off in
the SCVs at late growth phases with at least one of these RNAs,
SprD, that possesses a major role in virulence [102]. The lower
expression levels of the Sprs in the SCVs could also account for
their reduced pathogenicity compared to the normal phenotype.
Expression of another sRNA, Sau-13, is up in the normal
phenotype but down in the SCVs [8]. SCVs have electron transport
deficiencies [115,118]. Sau-13 could regulate ions’ transport and
metabolism by its antisense action against the alkaline phosphatase
precursor phoB. An sRNA, Sau-66, is only expressed in the SCVs
but absent in the normal phenotype [8]. Sau-66 has antisense
potential on a nearby gene coding for a protein involved in folate
biosyntheses. Since folate is a carbon donor during purine
biosynthesis, Sau-66 may influence the formation of thymidin-
auxotrophs SCVs [119]. Altogether, these data show that the
expression of a subset of S. aureus sRNAs is associated with preferred
phenotypes. The identification of their molecular targets, however,
will be required to assess their roles in phenotypes-associated
lifestyles and their putative implications in virulence.
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Conclusion
Recent advances in the characterization of the plethora of
regulatory RNAs expressed by S. aureus have provided novel
insights about how they monitor various cellular activities. Most of
the few sRNAs whose physiological roles have been determined
control the expression of genes involved in central metabolisms, in
response to quorum sensing, and on virulence by pairing to target
Figure 4. sRNAs from the S. aureus RNome implicated in bacterial virulence. Multitasking RNAIII is the effector of quorum sensing to
perceive bacterial population density and regulates multiple targets involved in peptidoglycan metabolism, adhesion, exotoxins production, and
virulence. RNAIII internally encodes hemolysin d (blue). RNAIII contains at least three repressor domains (red) containing accessible UCCC motifs that
interact, by antisense pairings, with the ribosome binding sites of numerous target mRNAs for translational repression (Tr.R), some triggering
endoribonuclease III (RNase III) cleavages to induce target mRNA degradations and irreversible gene expression decay. Translation of at least two
exotoxins is activated by RNAIII, one encoded (hld), and another (hla) by translation activation (Tr.A). SprD is expressed from the genome of a
converting phage and interacts, by antisense pairings, with the 59 part of the sbi mRNA encoding an immune evasion molecule. SprD possesses an
important role in S. aureus virulence, but the mechanism of its control is yet to be elucidated, with Sbi being only one player among others. The 891-
nucleotide long SSR42 affects extracellular virulence expression, hemolysis, neutrophil virulence, and pathogenesis and contains a putative internal
ORF. The mechanisms of target regulation remain to be elucidated. The SCCmec-encoded psm-mec RNA suppresses agrA translation and attenuates
MRSA virulence, acting as a dual-function RNA regulator.
doi:10.1371/journal.ppat.1003767.g004
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mRNAs to modulate their translational activities and stabilities.
Several sRNAs encode and express small peptides that may play
important roles in virulence or in bacterial growth control. As is
the case for some sRNAs expressed in other bacteria, it is likely
that other mechanisms of action are used by S. aureus sRNA such
as molecular mimicry (e.g. the 6S RNA) or binding to regulatory
proteins. The number of sRNAs identified in S. aureus has
considerably increased in the past decade, up to 250 members, but
the biological functions of most of them remain unknown. Some
sRNAs that are expressed from mobile genetic elements can
regulate target genes located on the core genome, as for SprD with
Sbi, implying an efficient functional integration of the accessory
genetic elements into the overall regulatory networks from the S.
aureus genome required for virulence. The sRNAs expressed from
the core genome probably are involved in wider biological
functions. Most of the well characterized sRNAs act as fine-tuning
regulators by repressing the translational level of only one gene
(Table 1), but it is likely that they target other genes and that one
gene is regulated by different sRNAs. The identification of their
molecular targets becomes a critical step to further understand
their roles in bacterial homeostasis and pathogenesis. Bioinfor-
matics approaches based on the prediction of sRNA base pairing
within the TIS of mRNAs allowed identifying antisense targets of
some sRNAs. However, these approaches often lead to false
positive predictions and do not highlight the interactions outside
the TIS that are not uncommon in S. aureus [44] and also in other
bacterial species. In rare cases, quantitative proteomics and
microarray analyses of sRNA mutant strains have allowed the
identification of target genes, but these genetic approaches are
not well suited to detect the primary targets of the sRNAs involved
in broad regulatory networks, such as RNAIII, which regulates
the expression of the Rot transcription factor. Until now, few
global regulatory sRNAs were identified. The identification of new
sRNAs that have an impact on the regulatory network control and
the characterization of mechanisms that allow them to connect
environmental responses to other cellular processes are future
challenges. In S. aureus, the characterization of sRNA functions
is complicated by the elevated genetic variability between the
strains. Such a high variance in the expression of virulence and
transcription factors among the S. aureus strains makes it difficult to
generalize the functional impacts of a given sRNA to all the S.
aureus strains. The characterization of the input of these sRNAs in
global gene expression will provide a better understanding of the
processes allowing the extraordinary adaptation of S. aureus in its
various environments and its elevated pathogenicity in humans
and animals. It should provide fundamental insights for potential
therapeutic applications in using some of these sRNAs as early
diagnostic markers and putative drug targets. Other future
challenges will be to comprehend the contribution of S. aureus
sRNAs during the various steps of the infectious process, host–
pathogen interactions, colonization, spread, and antibiotic resis-
tance. To tackle these ambitious goals, it will require developing
elegant technologies in living animals to analyze the implications
of the S. aureus RNome during infection.
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